New Zealand markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
42.86+0.06 (+0.14%)
At close: 4:02PM EDT
42.96 +0.10 (+0.23%)
Pre-market: 07:54AM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5231.67B
Enterprise value 3247.70B
Trailing P/E 18.95
Forward P/E 110.57
PEG ratio (5-yr expected) 11.66
Price/sales (ttm)4.21
Price/book (mrq)3.31
Enterprise value/revenue 34.46
Enterprise value/EBITDA 712.24

Trading information

Stock price history

Beta (5Y monthly) 0.69
52-week change 318.32%
S&P500 52-week change 331.29%
52-week high 351.86
52-week low 332.83
50-day moving average 343.62
200-day moving average 341.71

Share statistics

Avg vol (3-month) 332.12M
Avg vol (10-day) 321.17M
Shares outstanding 55.61B
Implied shares outstanding 6N/A
Float 85.6B
% held by insiders 10.04%
% held by institutions 167.41%
Shares short (29 Sep 2021) 452.18M
Short ratio (29 Sep 2021) 41.98
Short % of float (29 Sep 2021) 40.93%
Short % of shares outstanding (29 Sep 2021) 40.93%
Shares short (prior month 30 Aug 2021) 458.67M

Dividends & splits

Forward annual dividend rate 41.56
Forward annual dividend yield 43.64%
Trailing annual dividend rate 31.54
Trailing annual dividend yield 33.60%
5-year average dividend yield 43.70
Payout ratio 470.64%
Dividend date 305 Dec 2021
Ex-dividend date 403 Nov 2021
Last split factor 21054:1000
Last split date 316 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)03 Jul 2021

Profitability

Profit margin 23.80%
Operating margin (ttm)27.32%

Management effectiveness

Return on assets (ttm)5.45%
Return on equity (ttm)18.35%

Income statement

Revenue (ttm)55.52B
Revenue per share (ttm)9.96
Quarterly revenue growth (yoy)92.40%
Gross profit (ttm)33.33B
EBITDA 20.14B
Net income avi to common (ttm)12.32B
Diluted EPS (ttm)2.34
Quarterly earnings growth (yoy)59.40%

Balance sheet

Total cash (mrq)21.7B
Total cash per share (mrq)3.87
Total debt (mrq)39.24B
Total debt/equity (mrq)55.81
Current ratio (mrq)1.37
Book value per share (mrq)12.51

Cash flow statement

Operating cash flow (ttm)23.55B
Levered free cash flow (ttm)31.61B